TRELEGY ELLIPTA is used to treat asthma or chronic obstructive pulmonary disease (COPD). Asthma is when the muscles surrounding the smaller airways become tight (bronchoconstriction), swollen and ...

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of flare-ups.

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

Novartis has moved a step closer to EU approval of its three-drug asthma therapy Enerzair Breezhaler, and now looks set to beat a rival therapy from GlaxoSmithKline to market. Enerzair (formerly ...

Asthma affects about seven million children in the U.S. But kids who have asthma can lead normal, active lives with the right ...

Managing flare-ups begins with identifying and avoiding triggers. If pollen or poor air quality exacerbates your asthma, for ...

The following is a summary of “Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor ...

Patients with severe, uncontrolled asthma had significantly higher odds of improvement in asthma-related sleep disturbances ...

Asthma is the most common chronic disease of childhood and, in the latter part of the 20th century, reached epidemic proportions. Asthma is generally believed to result from gene-environment ...

However, people with severe asthma are prone to experiencing these symptoms chronically. "Severe asthma is asthma that ...

Losing weight with asthma can be challenging. Asthma can make breathing more difficult, so physical activity may be uncomfortable—especially if your asthma is exercise-induced. You may face other ...

If you have asthma, dogs may trigger your symptoms—but not everyone with the disease has the same response to these furry animals. Research suggests that about 33% of people with asthma are also ...